The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC
Videos  >  

Comparing Neoadjuvant Chemotherapy Versus Surgery in Ovarian Cancer Care

Emma Barber, MD
Published Online:1:21 PM, Thu June 1, 2017

Emma Barber, MD, UNC Department of Obstetrics and Gynecology, UNC School of Medicine, UNC Lineberger Comprehensive Cancer Center, discusses which patients with ovarian cancer are better candidates for neoadjuvant chemotherapy versus surgery.
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.